
    
      The study is comprised of 4 trial periods:

        1. Screening and washout (5-45 days)

        2. Baseline for assessment of the type, frequency, and severity of headaches (28-38 days)

        3. Treatment (12 weeks)

        4. Follow-up (12 weeks)
    
  